Expression of nephronectin is inhibited by oncostatin M via both JAK/STAT and MAPK pathways

FEBS Open Bio. 2015 Apr 8:5:303-7. doi: 10.1016/j.fob.2015.04.001. eCollection 2015.

Abstract

Nephronectin (Npnt), also called POEM, is an extracellular matrix protein considered to play critical roles as an adhesion molecule in the development and functions of various tissues, such as the kidneys, liver, and bones. In the present study, we examined the molecular mechanism of Npnt gene expression and found that oncostatin M (OSM) strongly inhibited Npnt mRNA expression in MC3T3-E1 cells from a mouse osteoblastic cell line. OSM also induced a decrease in Npnt expression in both time- and dose-dependent manners via both the JAK/STAT and MAPK pathways. In addition, OSM-induced inhibition of osteoblast differentiation was recovered by over-expression of Npnt. These results suggest that OSM inhibits Npnt expression via the JAK/STAT and MAPK pathways, while down-regulation of Npnt by OSM influences inhibition of osteoblast differentiation.

Keywords: BMP-2, bone morphogenetic protein-2; ERK, extracellular signal-regulated kinase; JAK, janus kinase; JAK/STAT; JNK, c-Jun N-terminal kinase; MAM, meprin, A5 protein, and receptor protein-tyrosine phosphatase μ; MAPK; MAPK, mitogen-activated protein kinase; MEF2, myocyte enhancer-binding factor 2A; Nephronectin; Npnt, nephronectin; OSM, oncostatin M; OSMR, OSM receptor; Oncostatin M; STAT, signal transducer and activator of transcription; TGF-β, transforming growth factor-β; TNF-α, tumor necrosis factor-α.